Preface | p. vii |
List or Contributors | p. ix |
The Clinical Challenge | |
Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease | p. 1 |
The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis | p. 23 |
Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction | p. 33 |
Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword | p. 75 |
Novel Mechanical and Molecular Concepts | |
Pampering and Priming the Heart | p. 85 |
Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization | p. 109 |
Integrative Pro-angiogenic Activation: HIF-1[alpha] | p. 123 |
The Maturation of Vessels - A Limitation to Forced Neovascularization? | p. 139 |
Vascular and Neuronal Development: Intersecting Parallelisms and Crossroads | p. 159 |
Cathelicidin Antimicrobial Peptides Modulate Angiogenesis | p. 191 |
Cell Therapy as an Option | |
The Biology of Embryonic and Adult Endothelial Progenitor Cells | p. 197 |
Signaling Behind Progenitor Cell Mobilization: Focus on eNOS and Caveolin | p. 215 |
The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth | p. 227 |
Index | p. 257 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.